By administering an intravenous bolus of insulin to induce severe hypoglycemia, the ITT stimulates a counter-regulatory response that evaluates the entire HPA axis [32] (sensitivity was recently reported to reach 100%, with specificity at 87% [30]). The gene discussed is INS; the disease is Hypoglycemia.